Cullen Capital Management’s Amgen AMGN Stock Holding History

Cullen Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-930	Closed	-$268K	–	199
2023 Q4	$268K	Sell	930 -966	-51%	-$263K	﹤0.01%	191
2023 Q3	$510K	Sell	1,896 -102	-5%	-$25.5K	0.01%	135
2023 Q2	$444K	Sell	1,998 -183	-8%	-$42.5K	﹤0.01%	235
2023 Q1	$527K	Hold	2,181	–	–	﹤0.01%	206
2022 Q4	$573K	Hold	2,181	–	–	0.01%	153
2022 Q3	$492K	Sell	2,181 -76	-3%	-$18.4K	0.01%	216
2022 Q2	$549K	Hold	2,257	–	–	0.01%	214
2022 Q1	$546K	Hold	2,257	–	–	0.01%	215
2021 Q4	$508K	Buy	2,257 +153	+7%	+$32.3K	﹤0.01%	227
2021 Q3	$447K	Sell	2,104 -756	-26%	-$174K	﹤0.01%	211
2021 Q2	$697K	Hold	2,860	–	–	0.01%	195
2021 Q1	$712K	Buy	+2,860	New	+$682K	0.01%	192

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cullen Capital Management's AMGN Position: Q1 2024 in Review

Cullen Capital Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 930 shares — an estimated $268K sold.

Cullen Capital Management first reported a position in AMGN in Q1 2021 and held it in 12 quarters. The position peaked at $712K in Q1 2021. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

Cullen Capital Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
Cullen Capital Management sold 930 Amgen shares in Q1 2024, an estimated $268K.
Cullen Capital Management first reported a position in Amgen in Q1 2021 and held it in 12 quarters.
Cullen Capital Management's Amgen position peaked at $712K in Q1 2021.
2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Cullen Capital Management's 13F filing for Q1 2024, filed 15 May 2024.